How does the 40-GEP test work?
Clinical Professor of Dermatology
Director, Melanoma Surveillance Clinic
Mount Sinai Icahn School of Medicine, New York, NY
Adjunct Professor, UT Southwestern Medical School
Consultant Dermatologist, Cooper Clinic, Dallas, TX
The 40-GEP test works using 40 genes, basically to assess prognosis and the degree of expression of those genes in combination with a proprietary formula, helps us better assess the prognosis in terms of whether patients will be in a low risk group, a medium risk group, or a high risk group, and therefore adjust our therapy accordingly.
In the video, Dr. Darrell Rigel explains how the 40-GEP test functions. The test involves the analysis of 40 specific genes to evaluate their expression levels. These genes are used in combination with a proprietary formula to determine a patient's prognosis. Based on the results, patients are categorized into low-risk, medium-risk, or high-risk groups. This classification helps medical professionals make more accurate assessments and tailor the appropriate treatment plan accordingly.
- The 40-GEP test utilizes 40 specific genes.
- Its primary purpose is to assess prognosis in medical cases.
- The test evaluates the degree of gene expression in combination with a proprietary formula.
- The evaluation helps categorize patients into different risk groups: low risk, medium risk, or high risk.
- The results of the test allow healthcare professionals to tailor treatment plans based on the risk group the patient falls into.
- By understanding the patient's risk level, the therapy can be adjusted accordingly to optimize treatment outcomes.